Month: January 2013

Smart Strategizing – Protection by shielding through Patent Evergreening in Pharmaceutical Domain with special reference to Roche v Cipla

Pankaj Mohanta, an intern at Khurana and Khurana talks about patent evergreening in the pharmaceutical domain. Through this post, he gives special emphasis on the recent landmark case of Roche v Cipla, which created quite a stir in the pharmaceutical industry. Needless to say, patent evergreening is that territory which falls in a bit of … Continue reading Smart Strategizing – Protection by shielding through Patent Evergreening in Pharmaceutical Domain with special reference to Roche v Cipla

Read more »

Two International Symposiums on Patent Portfolio Management Strategies for Pharma and Biotech Industry, (i) for R&D Scientists and IP Professionals, and (ii) for Business Development and Licensing Professionals (running concurrently)

About the Symposiums: These Symposiums feature presentation of all important patent issues, as mentioned in the brochure, related to two different groups i.e. Business Development and Licensing Professionals on one hand and R&D Scientists & IP Professionals on the other hand. Both these symposiums for different groups would run concurrently in the different Conference Halls … Continue reading Two International Symposiums on Patent Portfolio Management Strategies for Pharma and Biotech Industry, (i) for R&D Scientists and IP Professionals, and (ii) for Business Development and Licensing Professionals (running concurrently)

Read more »

Divisional Application

Pankaj Mohanta, an intern at Khurana and Khurana Advocates and IP Attorneys gives us an overview and analysis of divisional application. BACKGROUND: A divisional patent application is generally a fair basic patent application which differs from the parent application comprising of data, analysis, results and insights about a particular invention from a previously filed application. … Continue reading Divisional Application

Read more »